Phone Intervention Cost-Effective for Glycemic Control
Modest cost achieves small decrease in A1c; higher cost achieves goal of less than 7 A1c....
Advertisement
The incremental per capita costs of a telephone-based intervention that moderately improves glycemic control in adults with type 2 diabetes are modest, according to a study published online July 30 in Diabetes Care.
Clyde B. Schechter, M.D., from the Albert Einstein College of Medicine in New York City, and colleagues calculated the cost-effectiveness of a telephone-based behavioral intervention provided by health educators to improve glycemic control in adults with type 2 diabetes and compared it to an active control (print) intervention.
The researchers found that, for a mean 0.36 percentage point improvement of hemoglobin A1c, the intervention cost was $176.61 per person in the telephone group. For each incremental percentage point of A1C improvement, the cost-effectiveness ratio was $490.58, while the per-person incremental cost ratio for achieving an A1C of <7 percent over the one-year intervention was $2,617.35. The median of per capita cost was $175.82; the cost per percentage point reduction in A1C was $487.75; and the cost per person achieving the A1C goal was $2,312.88.
"The costs of a telephonic intervention for diabetes self-management support are moderate and commensurate to the modest associated improvement in glycemic control," the authors write.
DISCLAIMER: The content of this Website is independent of the views of our advertisers and sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.
Copyright @ 1999-2013 Diabetes In Control, Inc.. All rights reserved.